Optogenetics: implications for Alzheimer’s disease research and therapy

Molecular Brain

George Perry¹  Nima Rezaei²  Amirali Kalantari³  Parnian Shobeiri³  Parsa Mirzayi³ 

[1] Department of Biology and Neurosciences Institute, University of Texas at San Antonio (UTSA);Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN);School of Medicine, Tehran University of Medical Sciences (TUMS), Children’s Medical Center Hospital;

关键词: Alzheimer’s disease;    Optogenetics;    Neural circuits;    Neurodegeneration;    Synapse;    Molecular pathways;   

DOI  :  10.1186/s13041-022-00905-y

来源: DOAJ

【 摘 要 】

Abstract Alzheimer’s disease (AD), a critical neurodegenerative condition, has a wide range of effects on brain activity. Synaptic plasticity and neuronal circuits are the most vulnerable in Alzheimer’s disease, but the exact mechanism is unknown. Incorporating optogenetics into the study of AD has resulted in a significant leap in this field during the last decades, kicking off a revolution in our knowledge of the networks that underpin cognitive functions. In Alzheimer's disease, optogenetics can help to reduce and reverse neural circuit and memory impairments. Here we review how optogenetically driven methods have helped expand our knowledge of Alzheimer's disease, and how optogenetic interventions hint at a future translation into therapeutic possibilities for further utilization in clinical settings. In conclusion, neuroscience has witnessed one of its largest revolutions following the introduction of optogenetics into the field.

【 授权许可】

Unknown